GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » New Journey Health Technology Group Co Ltd (SZSE:002219) » Definitions » Long-Term Capital Lease Obligation

New Journey Health Technology Group Co (SZSE:002219) Long-Term Capital Lease Obligation : ¥66 Mil (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is New Journey Health Technology Group Co Long-Term Capital Lease Obligation?

New Journey Health Technology Group Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥66 Mil.

New Journey Health Technology Group Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (¥54 Mil) to Dec. 2023 (¥75 Mil) but then declined from Dec. 2023 (¥75 Mil) to Mar. 2024 (¥66 Mil).

New Journey Health Technology Group Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥55 Mil) to Dec. 2022 (¥47 Mil) but then increased from Dec. 2022 (¥47 Mil) to Dec. 2023 (¥75 Mil).


New Journey Health Technology Group Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for New Journey Health Technology Group Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Journey Health Technology Group Co Long-Term Capital Lease Obligation Chart

New Journey Health Technology Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.71 55.34 47.00 74.70

New Journey Health Technology Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.15 55.94 54.17 74.70 65.87

New Journey Health Technology Group Co  (SZSE:002219) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

New Journey Health Technology Group Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of New Journey Health Technology Group Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


New Journey Health Technology Group Co (SZSE:002219) Business Description

Traded in Other Exchanges
N/A
Address
Duyiyi Industrial Park, Wangba, Kang County, Gansu Province, Longnan, CHN, 610000
New Journey Health Technology Group Co Ltd formerly Hengkang Medical Group Co Ltd is engaged in research, development, and manufacturing of natural herbal medicines. The company's products include analgesic and haemostatic drugs.
Executives
Song Li Hua Directors, executives
Yu Mei Directors, executives
Wang Yong Executives
Zuo Bin Lin Executives
Tang Can Director
Duan Zhi Ping Director
Zhou Xian Min Director
Guo Kai Executives
Xie Hai Executives
Shi Xiao Ming Executives
Li Yu Fei Supervisors
Huang Rui Directors, executives
Pan Yu Supervisors
Liao Li Dong Executives

New Journey Health Technology Group Co (SZSE:002219) Headlines

No Headlines